Today: 1 May 2026
ServiceNow stock price falls again as Wall Street redraws the AI winners list
7 February 2026
2 mins read

ServiceNow stock price falls again as Wall Street redraws the AI winners list

New York, Feb 6, 2026, 17:43 EST — After-hours

  • ServiceNow slipped, weighed down by lingering volatility across software stocks.
  • Investors continued to debate if AI boosts subscription software—or ends up upending it.
  • Investors now eye a slate of tech executives set to appear at upcoming conferences.

ServiceNow, Inc. (NOW.N) dropped 1.8% to $100.74 Friday, then held steady in after-hours trading. The stock moved between $99.02 and $105.54 during the session. Roughly 34.7 million shares traded hands.

ServiceNow isn’t escaping the “software-mageddon” that’s hammering cloud and SaaS stocks — that is, online subscription software — as investors increasingly draw a line between AI winners and losers. Over the past week, the S&P 500 Software & Services index slid roughly 13%; since peaking in late October, it’s lost about 25%, erasing more than $800 billion in value. “Perhaps this is an overreaction, but the threat is real,” Ocean Park Asset Management CIO James St. Aubin said. reuters.com

The split in the AI sector is getting sharper. Shares of ServiceNow are off 12% this week, Salesforce down 9%. Hardware stocks, especially those linked to data-center expansion, are holding up better as investors shift focus. Charu Chanana, chief investment strategist at Saxo, described the divergence as “not a vote against AI,” but more a question of who stands to enable the shift and who might get left behind. reuters.com

Friday saw a sharp rebound for U.S. stocks. The Dow broke through the 50,000 mark for the first time, while the S&P 500 climbed 2% as Nvidia surged almost 8%. Software names managed to recover as well: the S&P 500 software and services index gained 2.4%, halting a seven-day slide. Still, the sector ended up with its worst week since March 2020.

No real signs of bargain hunters. ServiceNow gave up 7.6% Thursday, while the S&P 500 software and services index dropped 4.6% and is now down about $1 trillion in value since Jan. 28. The index sits roughly 21% under its 200-day moving average—a key long-term marker. Ben Snider, chief U.S. equity strategist at Goldman Sachs, said near-term earnings might hold up, but they’re “insufficient to disprove the long-term downside risk.” reuters.com

Late last month, ServiceNow projected its fiscal 2026 subscription revenue would land between $15.53 billion and $15.57 billion. The company also cleared a fresh $5 billion for buybacks. ServiceNow is pushing AI deeper into its platform, linking up with Anthropic—the Claude chatbot developer—and OpenAI, the group behind ChatGPT, as it chases the next wave of autonomous AI “agents” that handle tasks with minimal human involvement. reuters.com

According to a filing, vice chairman Nicholas Tzitzon picked up 10,004 performance-based restricted stock units on Feb. 3. He’ll need to stick around until Feb. 7 for the award to vest. The document notes this was the first of two tranches linked to performance targets for the 2024–2025 period.

Coming up: ServiceNow’s Lou Fiorello, group VP and general manager for risk and security products, will speak on a Securing AI panel at the Bernstein TMT Forum on Feb. 25. CEO Bill McDermott is slated for a fireside chat at the Morgan Stanley TMT Conference on March 4.

Stock Market Today

  • Seaport Therapeutics Upsizes IPO to $255M, CEO Highlights New Biotech Pathway
    May 1, 2026, 2:02 PM EDT. Seaport Therapeutics raised $254.9 million in an upsized Nasdaq IPO, exceeding initial $180 million estimates. CEO Daphne Zohar highlighted a shift from traditional M&A (mergers and acquisitions) to public offerings, reflecting confidence in developing and marketing their depression drug pipeline independently. The company may raise an additional $38.2 million through underwriters' option. Zohar pointed to industry changes where biotech firms are now focusing on advancing medicines directly to patients, citing success stories like Karuna Therapeutics and Intra-Cellular Therapies. Seaport's board recently welcomed Sharon Mates, who led Intra-Cellular to a $1.5 billion drug launch before its J&J acquisition. This IPO signals renewals in the biotech public market despite recent Big Pharma dealmaking.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Oracle stock rebounds after a bruising week — what traders are watching next for ORCL
Previous Story

Oracle stock rebounds after a bruising week — what traders are watching next for ORCL

Western Digital stock jumps nearly 9% — WDC rally turns on targets, AI storage talk
Next Story

Western Digital stock jumps nearly 9% — WDC rally turns on targets, AI storage talk

Go toTop